| 标题 |
S1450 Duvakitug, an Anti-TL1a mAb, Demonstrates Efficacy and Favorable Safety as an Induction Treatment in Adults With Moderately to Severely Active Crohn’s Disease: Results From the RELIEVE UCCD Phase 2b Basket Trial |
| 网址 | |
| DOI |
10.14309/01.ajg.0001133260.88461.65
doi
|
| 其它 |
期刊:American Journal of Gastroenterology 作者:V. Jairath; J. Kierkuś; A. Duvall; S. Danese; B. Sands; et al 出版日期:2025-10-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)